Digital Pharmacist

SEPTEMBER 20, 2023

The Medicare Open Enrollment period for 2024 is quickly approaching – this is a critical time for both your patients and your pharmacy. Below is a breakdown of what you need to be aware of when assisting patients with 2024 open enrollments, as well as a few tips on how your pharmacy can prepare for this busy time at the pharmacy.

Independent Pharmacies 105

Independent Pharmacies Insurance Nursing Homes Immunization 105

Digital Pharmacist

AUGUST 21, 2023

As we gear up for the upcoming flu season of 2023-2024, it’s important to reflect on the lessons of the previous year , and understand how the coming year may look different. 2023 Flu Vaccination Changes As we look at the 2023-2024 flu season, what’s new for this year? According to the CDC, in the 2023-2024 season, the U.S.

Vaccines 98

Vaccines Communication Immunization 98

Pharma Mirror

JANUARY 19, 2024

As we step into 2024, the global life science industry finds itself at a crossroads, facing plenty of challenges alongside an abundance of exciting opportunities. The pharmaceutical and contract outsourcing space has shifted, with new trends emerging that will shape the future of this rapidly changing industry.

Vaccines 52

Vaccines 52

IDStewardship

APRIL 14, 2024

In this article a comparison of Rebyota versus Vowst is provided, to help learners differentiate these two fecal microbiota therapies. Article Posted 14 April 2024 What is Clostridioides difficile ? Authored by: Natalie Boyer, Pharm.D. Candidate 2025 Mentored by: Christina G. O’Connor, Pharm.D., While it is normal for C.

FDA 324

FDA Hospitals Communication 324

The FDA Law Blog

OCTOBER 16, 2023

Gonzalez — The Wall Street Journal (WSJ) recently published a series of articles as part of its special report “What’s Ahead for Artificial Intelligence.” Three of these articles focus on medical applications of Artificial Intelligence and Machine Learning (AI/ML) and explore FDA’s role in regulating such products.

Documentation 119

Documentation FDA 119

Hospital Pharmacy Europe

JANUARY 16, 2024

From 2024, all UK registered pharmacists and pharmacy technicians are eligible to apply to the PRUK research grant schemes. The application deadline is 1pm on 27 March 2024. Applicants will be notified of the initial outcome in the week commencing 1 July 2024, with online interviews taking place on 9 July.

Hospitals 105

Hospitals Patient Care 105

European Pharmaceutical Review

AUGUST 3, 2023

EPC’s new Cannabis flower monograph The new monograph Cannabis flower (Cannabis flower, monograph 3028) will be available next year in January 2024 with publication of the supplement 11.5. The monograph will enter into force several months later, in July 2024. 1 July 2024).

Compounding 98

Compounding Pharmaceutical Companies Pharmaceutical Companies 98

IDStewardship

OCTOBER 18, 2023

In this article the students from the University of Florida discuss why they started the ChatRx podcast and what their goals are for their new endeavor. Candidate 2024 & Lucas Zhou, Pharm.D. Candidate 2024 Article Posted October 2024 Hello Readers of IDstewardship! Written By: Eisha Ludtke, Pharm.D.

182

182

European Pharmaceutical Review

JANUARY 5, 2024

In EPR’s article last month which discussed predictions for the biopharma industry in 2024 , Subin Baral, EY Global Deals Leader, Life Sciences stated: “Given the unmet need, we expect oncology to continue to dominate dealmaking in 2024.”

102

102

PQA

DECEMBER 15, 2023

PQA invites your comments on a draft call to action through Friday, January 12, 2024, at 11:59 p.m. Considering Differential Pharmacy Reimbursement Troy Trygstad, executive director of CPESN USA, shared insights on differential reimbursement in a new opinion article. Your input will help PQA finalize the call to action. Learn more.

Community Pharmacies 59

Community Pharmacies Patient Care 59

Hospital Pharmacy Europe

JANUARY 4, 2024

Both pharmacy professionals with specialist expertise in genomics and those in the early stages of their career can apply, with expressions of interest to be submitted via an online form by 15 January 2024. A version of this article was originally published by our sister publication The Pharmacist.

Hospitals 103

Hospitals 103

European Pharmaceutical Review

JANUARY 29, 2024

During 2023, there were five revisions to the European Medicines Agency ’s (EMA’s) Questions and Answers (Q&As) for marketing authorisation holders/applicants on the CHMP Opinion for the Article 5(3) of Regulation (EC) No 726/2004 referral on nitrosamine impurities in human medicinal products. These changes are summarised in Table 1.

FDA 96

FDA Vaccines Compounding 96

STAT

FEBRUARY 1, 2024

On 2024 guidance, Merck said it expects sales in the range of $62.7-$64.2 In 2024, as in 2023, the industry’s fate seems inextricable from interest rates. If you’ve made it to the end of this article, you might be interested in joining this  secret list for an upcoming biotech newsletter.

Vaccines 107

Vaccines Communication Insurance 107

European Pharmaceutical Review

MARCH 5, 2024

In an earlier EPR article on haematology/oncology clinical development , Dr Terwey described how BeiGene is seeking to address clinical development challenges, particularly in mitigating the impact of drug shortages on clinical trials in Europe.

Medical Schools 91

Medical Schools 91

Hospital Pharmacy Europe

APRIL 15, 2024

‘Phase 3 trial data of the effects of two years exposure to exenatide in patients with Parkinson’s disease will hopefully address this question and will be available in the second half of 2024,’ Professor Foltynie added. This was followed by the drug‘s approval in the European Union in January 2024.

Hospitals 59

Hospitals 59

European Pharmaceutical Review

AUGUST 25, 2023

It is important to note that Point 8.123 is postponed and will not be effective in Annex 1 until 25 August 2024. EPR Issue 4 2023: Annex 1 and CCS EPR ’s upcoming Issue 4 contains an article on developing an effective contamination control strategy (CCS). This covers lyophilisers, also known as pharmaceutical freeze dryers.

Documentation 92

Documentation 92

The FDA Law Blog

NOVEMBER 9, 2023

Pursuant to FSMA, FDA amended the requirements for prior notice of imported food, to include a requirement to report the name of any country to which the article has been refused entry. The proposed rule also establishes a timeframe by which food articles subject to refusals or holds must become compliant.

FDA 52

FDA 52

European Pharmaceutical Review

MAY 26, 2023

According to the MHRA, the recognition routes mark the start of a new international recognition framework for medicines that will be in place by the first quarter of 2024. Read the article on Boehringer Ingelheim’s ILAP designation here. This is a rare tumoural cancer which has not seen new first-line treatment in over forty years.

Vaccines 85

Vaccines 85

The Spirit Pharmacist

MAY 1, 2024

If looking for a primer on ST or want to dig deeper into the toxidrome you can check out this blog , webinar , or journal article I have on the subject. Published 2024 Feb 29. Published 2024 Feb 29. This is likely because psilocybin and psilocin lack the requisite pharmacologic activity to cause ST. 2024;26(1):23cr03648.

Hospitals 98

Hospitals FDA 98

The FDA Law Blog

DECEMBER 6, 2023

The support FDA offers for its proposition – which comes from a mixture of sources, including a few published scientific articles, newspaper stories, FDA’s experience with LDTs with COVID, anecdotes, older case studies, and class action lawsuits – is singularly unconvincing.

FDA 59

FDA 59

Pharmaceutical Technology

OCTOBER 30, 2022

Undefined’s ionic propulsion drone has completed an outside flying test and plans to go on sale in 2024. This article was originally published in Verdict.co.uk. It intends to have flights of 15 minutes duration that are free of noise limitations for the last-mile cargo delivery industry by the end of 2023.

52

52

PQA

FEBRUARY 7, 2024

PQA’s PST-INS measure will be added to the Medicare Part D Display Page for 2024 and 2025. For further details on the evidence for PST-INS, refer to the full article. The PST-INS measure has been included in the Part D Patient Safety reports provided confidentially to plan sponsors since the 2022 measurement year.

Insurance 52

Insurance Hospitals 52

Hospital Pharmacy Europe

MARCH 7, 2024

Open Access Article under the CC BY License. Open Access Article under the CC BY License. 2022 (accessed March 2024) Turgeon RD et al. 2022 (accessed March 2024) CAPRIE Steering Committee. accessed March 2024) Magavern E et al. 2023 (accessed March 2024). JACC Adv 2023;2(7):100573. JACC Adv 2023;2(7):100573.

Hospitals 52

Hospitals Labelling 52

Hospital Pharmacy Europe

JUNE 23, 2023

For the over-75s there are currently three vaccine products in development by GSK , Pfizer and Moderna which are due to be licensed this year or early 2024, all of which should be considered, the committee said. This article was originally published by our sister title Pulse.

Vaccines 98

Vaccines Hospitals 98

Hospital Pharmacy Europe

NOVEMBER 2, 2023

To support the documents, in spring 2024 the RPS will launch a Greener Pharmacy Toolkit, allowing pharmacies to self-accredit their sustainability status. A version of this article was originally published by our sister publication The Pharmacist.

Hospitals 52

Hospitals Community Pharmacies Documentation Communication 52

Hospital Pharmacy Europe

AUGUST 21, 2023

The Government’s National Action Plan goal was to reduce prescribing by 15% by 2024 from a 2014 baseline. This article was originally published by our sister publication Pulse The post Greater use of diagnostic tests to help tackle antimicrobial resistance is required appeared first on Hospital Pharmacy Europe. between 2017 and 2021.

Hospitals 52

Hospitals Vaccines 52

ISPE

JULY 3, 2023

Rutherford 1 July 2023 It is starting to become more real that my term as Chair is winding down because the 2023–2024 International Board elections are happening. Lee is co-author of the article " Removing Regulatory Hurdles for Continuous Pharmaceutical Manufacturing."

Dosage 52

Dosage 52

IDStewardship

APRIL 13, 2023

In this article an infectious diseases pharmacist with experience managing antimicrobial stewardship programs discusses antimicrobial stewardship regulatory standards Authored by: Timothy P. Gauthier, Pharm.D., difficile infection, adverse effects, antibiotic resistance, hospital costs, and hospital length of stay.

Hospitals 236

Hospitals Documentation Communication Patient Care 236

The FDA Law Blog

DECEMBER 20, 2023

This will apply to all meeting requests received on January 22, 2024, or later. As reported in this recent Pink Sheet article , FDA staff recently noted that a substantial majority of meeting requests for eligible in-person meeting types have not been requested as such.

FDA 59

FDA 59

Hospital Pharmacy Europe

NOVEMBER 23, 2023

The level of annual allowed growth in sales of branded medicines will double from 2% in 2024 to 4% by 2027. Under the agreement, which comes into force in 2024, the pharmaceutical industry will also invest £400m over five years through the Life Sciences Investment Programme.

Hospitals 52

Hospitals Vaccines 52

The Happy PharmD

AUGUST 30, 2023

Part two is supposed to come out in June 2024. A few months ago, I wrote an article about my girlfriend’s difficulties with a Dexamethasone liquid prescription. In the article, I discussed the problems that my girlfriend and I encountered in obtaining the medication. So that was part one— this is part two.

Medication Dispensing 52

Medication Dispensing Insurance 52

The Checkup by Singlecare

FEBRUARY 1, 2024

When to talk to a healthcare provider about naltrexone interactions While many naltrexone interactions are discussed in this article, there may be other interactions we haven’t discussed. Additionally, report any new or worsening symptoms of your medical conditions, as this may be another sign of a drug interaction.

Communication 92

Communication Dosage FDA 92

Hospital Pharmacy Europe

AUGUST 21, 2023

A new standardised Medical Licensing Assessment (MLA) is set to be introduced in 2024, and will be required for all UK and international medical graduates. This article was originally published by our sister publication The Pharmacist The post Should pharmacist prescribers take the prescribing safety assessment?

Medical Schools 52

Medical Schools Community Pharmacies Hospitals 52

The Thyroid Pharmacist

NOVEMBER 29, 2023

At this time, shipping is not available outside of the US, and I know many of you have been asking about this, so I will add it to my list of projects to research in 2024. We have 95 expiring in March 2024.) We have 106 expiring in April 2024.) We have 35 expiring in May 2024, and 139 expiring in August 2024.)

Health and Personal Care Stores 54

Health and Personal Care Stores Immunization Labelling Dosage 54

IDStewardship

JULY 27, 2022

In this article antimicrobial stewardship in the United Kingdom is discussed. Article posted 1 August 2022. In England, high-level targets for antimicrobial use are set out in the 2019 – 2024 National UK AMR action plan. The target for the overall usage of antimicrobials is a reduction of 15% by 2024. Gauthier, Pharm.D.,

Hospitals 147

Hospitals Clinic Management Labelling Vaccines 147

European Pharmaceutical Review

AUGUST 3, 2023

Even prior to the initial grant of its accelerated approval in 2021, high profile scientific journals carried articles questioning whether the FDA should rush to approve what turned out to be the first treatment approved for Alzheimer’s disease in 20 years 4. This would be a welcome boost for Alzheimer’s sufferers in Europe.

FDA 52

FDA 52

The People's Pharmacy

JUNE 15, 2023

” Will the US Have a Bad Flu Season 2023-2024? Check out our recent article about HMPV at this link. Here is a link to our article titled: Will Flu Shots Protect You from Alzheimer Disease? of influenza A(H1N1) isolates, 74.2% of influenza A(H3N2) isolates, and 98.5% I have every intention of getting a flu shot this year.

Vaccines 76

Vaccines 76